A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure.
BACKGROUND:In humans, stillbirth describes the death of a fetus before birth after 28 weeks gestation, and accounts for approximately 2.6 million deaths worldwide annually. In high-income countries, up to half of stillbirths have an unknown cause and are described as "unexplained stillbirths&qu...
Main Authors: | Heba Shawer, Esther Aiyelaagbe, Christopher Clowes, Samantha C Lean, Yinhui Lu, Karl E Kadler, Alan Kerby, Mark R Dilworth, Kathryn E Hentges, Alexander E P Heazell |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233007 |
Similar Items
-
Altered fetal growth, placental abnormalities, and stillbirth.
by: Radek Bukowski, et al.
Published: (2017-01-01) -
Abnormal placental perfusion and the risk of stillbirth: a hospital-based retrospective cohort study
by: Jiang-Nan Wu, et al.
Published: (2021-04-01) -
Analysis of ErbB Receptors: Regulation of ErbB-1 Kinase Activation and Localization of ErbB-4 to Membrane Microdomains
by: Thiel, Kristina Wyatt
Published: (2007) -
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01) -
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
by: Diego Alvarado, et al.
Published: (2017-01-01)